{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:38:38Z","timestamp":1788068318803,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2025RC1020"],"award-info":[{"award-number":["2025RC1020"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172878"],"award-info":[{"award-number":["82172878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373435"],"award-info":[{"award-number":["82373435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jbc.2025.110941","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:19:05Z","timestamp":1763345945000},"page":"110941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrin \u03b24 drives immune evasion and therapeutic resistance to PD-1 blockade in bladder cancer via MEK\/ERK signaling"],"prefix":"10.1016","volume":"302","author":[{"given":"Pingxia","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110941_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jbc.2025.110941_bib2","article-title":"Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma","volume":"4","author":"Qu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jbc.2025.110941_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jbc.2025.110941_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-024-01945-9","article-title":"Multi-cohort validation of ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer","volume":"23","author":"Xie","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2025.110941_bib5","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jbc.2025.110941_bib6","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2025.110941_bib7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial","volume":"22","author":"Powles","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbc.2025.110941_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","article-title":"NCCN Guidelines(R) insights: Bladder cancer, version 2.2022","volume":"20","author":"Flaig","year":"2022","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.jbc.2025.110941_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2025.110941_bib10","article-title":"G3BP1 and SLU7 jointly promote immune evasion by downregulating MHC-I via PI3K\/Akt activation in bladder cancer","volume":"11","author":"Zheng","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jbc.2025.110941_bib11","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3390\/cells13221919","article-title":"Cell adhesion molecules as modulators of the epidermal growth factor receptor","volume":"13","author":"Kozlova","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2025.110941_bib12","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/acsomega.4c08140","article-title":"Role of cell adhesion in cancer metastasis formation: a review","volume":"10","author":"Burcik","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.jbc.2025.110941_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108998","article-title":"Utilizing machine learning to integrate single-cell and bulk RNA sequencing data for constructing and validating a novel cell adhesion molecules related prognostic model in gastric cancer","volume":"180","author":"Chen","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jbc.2025.110941_bib14","article-title":"Characteristics of cell adhesion molecules expression and environmental adaptation in yak lung tissue","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.110941_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1590\/S1677-55382012000400005","article-title":"Immune expression of E-cadherin and alpha, beta and gamma-catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas","volume":"38","author":"Reis","year":"2012","journal-title":"Int. Braz. J. Urol."},{"key":"10.1016\/j.jbc.2025.110941_bib16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s13258-019-00868-w","article-title":"Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer","volume":"41","author":"Liao","year":"2019","journal-title":"Genes Genomics"},{"key":"10.1016\/j.jbc.2025.110941_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/1471-2407-13-410","article-title":"ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma","volume":"13","author":"Nagata","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2025.110941_bib18","article-title":"Molecular typing of gliomas on the basis of integrin family genes and a functional study of ITGA7","volume":"15","author":"Han","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.110941_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/path.1472","article-title":"Integrins in regulation of tissue development and function","volume":"201","author":"Danen","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.jbc.2025.110941_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bies.950180809","article-title":"Epithelial integrins","volume":"18","author":"Sheppard","year":"1996","journal-title":"Bioessays"},{"key":"10.1016\/j.jbc.2025.110941_bib21","article-title":"The mechanism of ITGB4 in tumor migration and invasion","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbc.2025.110941_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13045-023-01413-9","article-title":"Tumor cell integrin beta4 and tumor stroma E-\/P-selectin cooperatively regulate tumor growth in vivo","volume":"16","author":"Genduso","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2025.110941_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/PAS.0000000000001451","article-title":"Integrin beta4 is an effective and efficient marker in synchronously highlighting lymphatic and blood vascular invasion, and perineural aggression in malignancy","volume":"44","author":"Li","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jbc.2025.110941_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s13402-025-01039-8","article-title":"Enhanced ZBTB10 expression induced by betulinic acid inhibits gastric cancer progression by inactivating the ARRDC3\/ITGB4\/PI3K\/AKT pathway","author":"Huang","year":"2025","journal-title":"Cell Oncol. (Dordr)"},{"key":"10.1016\/j.jbc.2025.110941_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177102","article-title":"Up-regulated ITGB4 promotes hepatocellular carcinoma metastasis by activating hypoxia-mediated glycolysis and cancer-associated fibroblasts","volume":"986","author":"Mai","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110941_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113564","article-title":"ITGB4\/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis","volume":"144","author":"Huang","year":"2025","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.jbc.2025.110941_bib27","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/cancers16213683","article-title":"Integrin alpha6beta4 upregulates PTPRZ1 through UCHL1-Mediated Hif-1alpha nuclear accumulation to promote triple-negative breast cancer cell invasive properties","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2025.110941_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/or.2022.8302","article-title":"SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK\/PI3K\/AKT signaling pathway through ITGB4","volume":"47","author":"Shi","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2025.110941_bib29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1158\/1541-7786.MCR-21-0994","article-title":"KRAS mutants upregulate integrin beta4 to promote invasion and metastasis in colorectal cancer","volume":"20","author":"Choi","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110941_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/ijc.34146","article-title":"Integrin alpha 6 is upregulated and drives hepatocellular carcinoma progression through integrin alpha6beta4 complex","volume":"151","author":"Zheng","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2025.110941_bib31","first-page":"414","article-title":"KCNF1 promotes lung cancer by modulating ITGB4 expression","volume":"30","author":"Chen","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jbc.2025.110941_bib32","first-page":"2183","article-title":"Integrin beta4 reduces DNA damage-induced p53 activation in colorectal cancer","volume":"40","author":"Wu","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2025.110941_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-022-01646-1","article-title":"A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer","volume":"21","author":"Schinke","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2025.110941_bib34","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.21037\/tlcr-24-50","article-title":"TFAP2A-activated ITGB4 promotes lung adenocarcinoma progression and inhibits CD4(+)\/CD8(+) T-cell infiltrations by targeting NF-kappaB signaling pathway","volume":"13","author":"Pan","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.jbc.2025.110941_bib35","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s12094-024-03527-z","article-title":"ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis","volume":"26","author":"Zhang","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jbc.2025.110941_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/imm.13890","article-title":"ITGB4\/BNIP3 activates autophagy and reduces MHC-I expression to mediate tumour immune escape in pancreatic cancer cell lines","volume":"174","author":"Zhou","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.jbc.2025.110941_bib37","first-page":"106","article-title":"Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1\/2 signaling pathway","volume":"20","author":"Meng","year":"2020","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.jbc.2025.110941_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2438291","article-title":"Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer","volume":"14","author":"Canizo","year":"2025","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jbc.2025.110941_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101103","article-title":"Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis","volume":"60","author":"Nakagawa","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2025.110941_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s11658-023-00471-8","article-title":"EFEMP2 upregulates PD-L1 expression via EGFR\/ERK1\/2\/c-Jun signaling to promote the invasion of ovarian cancer cells","volume":"28","author":"Shen","year":"2023","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.jbc.2025.110941_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70479","article-title":"Real-life impact of enfortumab vedotin or chemotherapy in the sequential treatment of advanced urothelial carcinoma: the ARON-2 retrospective experience","volume":"14","author":"Rizzo","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.jbc.2025.110941_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100753","article-title":"Spatial expression of HER2, NECTIN4, and TROP-2 in muscle-invasive bladder cancer and metastases: implications for pathological and clinical management","volume":"38","author":"Dernbach","year":"2025","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jbc.2025.110941_bib43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab vedotin in previously treated advanced urothelial carcinoma","volume":"384","author":"Powles","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.110941_bib44","article-title":"S100A5 attenuates efficiency of Anti-PD-L1\/PD-1 immunotherapy by inhibiting CD8(+) T cell-mediated anti-cancer immunity in bladder carcinoma","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jbc.2025.110941_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.110941_bib46","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.21037\/jgo-24-612","article-title":"Application of integrin subunit genes in pancreatic cancer and the construction of a prognosis model","volume":"15","author":"Ye","year":"2024","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.jbc.2025.110941_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-020-00357-7","article-title":"IFN-gamma surmounts PD-L1\/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells","volume":"6","author":"Dong","year":"2021","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2025.110941_bib48","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1002\/cam4.4216","article-title":"ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer","volume":"10","author":"Jiang","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.jbc.2025.110941_bib49","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0092-8674(00)80486-9","article-title":"Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion","volume":"91","author":"Shaw","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110941_bib50","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1128\/MCB.25.14.6090-6102.2005","article-title":"Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration","volume":"25","author":"Nikolopoulos","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110941_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169241","article-title":"FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression","volume":"134","author":"Okato","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2025.110941_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1158\/0008-5472.CAN-19-1145","article-title":"Integrin beta4-Targeted cancer immunotherapies inhibit tumor growth and decrease metastasis","volume":"80","author":"Ruan","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110941_bib53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.ircmb.2024.08.004","article-title":"Nectin-4: a promising prognostic marker and therapeutic target in cancer","volume":"391","author":"Kuttikrishnan","year":"2025","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.jbc.2025.110941_bib54","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11864-022-00940-w","article-title":"Nectin-4: a novel therapeutic target for skin cancers","volume":"23","author":"Hashimoto","year":"2022","journal-title":"Curr. Treat Options Oncol."},{"key":"10.1016\/j.jbc.2025.110941_bib55","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/0008-5472.CAN-15-1313","article-title":"Enfortumab vedotin antibody-drug conjugate targeting Nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models","volume":"76","author":"Challita-Eid","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110941_bib56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/annonc\/mdw678","article-title":"Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer","volume":"28","author":"M","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbc.2025.110941_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41585-020-00394-5","article-title":"The biology and rationale of targeting nectin-4 in urothelial carcinoma","volume":"18","author":"Heath","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jbc.2025.110941_bib58","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/14712598.2021.1929168","article-title":"Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma","volume":"21","author":"Wong","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jbc.2025.110941_bib59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biocel.2018.07.011","article-title":"The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-beta4","volume":"102","author":"Siddharth","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110941_bib60","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00358","article-title":"A role for PVRL4-driven cell-cell interactions in tumorigenesis","volume":"2","author":"Pavlova","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2025.110941_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1158\/1535-7163.MCT-19-0183","article-title":"ERK inhibitor LY3214996 targets ERK pathway-driven cancers: a therapeutic approach toward precision medicine","volume":"19","author":"Bhagwat","year":"2020","journal-title":"Mol. Cancer Ther."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825027930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825027930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:22:36Z","timestamp":1773879756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825027930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0021925825027930"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110941","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrin \u03b24 drives immune evasion and therapeutic resistance to PD-1 blockade in bladder cancer via MEK\/ERK signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110941"}}